Tim Frank Andersen on stage in front of a large conference audience

Keynote speaker & moderator on AI and technology

Tim FrankAndersen

I’ve worked in tech for 30 years. Right now the big shift is AI
- I help organisations understand what’s real, what’s next, and what’s in it for them.

Today’s AI news, every morning

Free. No spam. Easy to unsubscribe.
Read today’s news →

Today in AI
  • An AI picked the treatment, then operated on a mouse
  • Apple's AI in China will run on Alibaba's model
  • The people building Europe's AI data centres
  • OpenAI loosens the brakes on biology, for a guest list
  • Musk's xAI must answer for its gas turbines in court

About

Tim Frank Andersen

Thirty years in tech - from founding one of Denmark’s first digital agencies to co-founding institute of AI. Author, tech expert on TV, and advisor to some of the world’s biggest brands.

More about Tim →

Speaking

Two ways to book Tim

See speaking →

Format 01

Keynote - The AI Explosion

What’s real, what’s next, and what’s in it for you. Live demos, honest answers, and a look at the next 12-24 months, which will change our world.

Format 02

Moderator

The person tying it all together - sharp questions and a clear thread through your conference.

What organisers say

Rated 5.0 from 11 reviews.

“I’ve heard plenty of talks about AI, and never found it more captivating or relevant than yours.”

Rikke Ekelund

“He inspired us all. Not a generic set of examples, but real, recent insight - told with genuine care for the work we do.”

Marc Amin

“Thank you for an extremely exciting talk - on a topic every company will relate to. Exciting to think about where we’ll be in 5 years: we must see opportunities, not limitations.”

Gitte Taulov Rude, Senior Business Advisor, Danske Bank

Updated every day

Today in AI - 5 curated news stories that matter

Curated by Tim, every morning.

Today · 01 Nov 2026
  1. 01

    An AI picked the treatment, then operated on a mouse

    Most of us still think of AI as a writing tool. The founder of Exin Therapeutics, an Oxford-linked biotech startup, described on Friday how Anthropic's Claude Sonnet 5 picked a gene therapy for an epileptic mouse. It then chose the spot in the mouse's brain and steered a robotic injector there. A vet approved every irreversible step, and the mouse recovered. The part I keep thinking about: halfway through, the AI refused to go on because its target was out of reach, and it was right. It is one researcher's account, not yet peer reviewed, but an AI that halts surgery when the numbers are wrong is the kind you want in a lab.

  2. 02

    Apple's AI in China will run on Alibaba's model

    If you buy an iPhone in China, the AI inside it will soon be Chinese. Alibaba said on Saturday that Qwen, its AI model, will power Apple's AI features there, starting with developer testing on Wednesday and reaching users in December. Apple had little choice, because China only allows AI services built on models its regulator has approved, and the big American models are not on that list. Apple's new CEO, John Ternus, said the same week that Apple does not want to ship AI for AI's sake. In China, Apple ships the AI the government allows, and any Western company selling AI there faces the same deal.

  3. 03

    The people building Europe's AI data centres

    The AI boom has a building site, and part of it is close to home. Investigate Europe, a cross-border team of journalists, published a five-month investigation on Friday into the migrant workers building data centres for Google, Microsoft and Amazon in Europe. They found a worker badly injured by a live cable at a Google site in Belgium, tuberculosis in workers' housing in Sweden and 60-hour weeks without overtime pay. The tech giants point to their suppliers' contracts, which is where responsibility tends to disappear. One crew from Sweden moved on to Microsoft's site in Høje Taastrup near Copenhagen this spring, so if your company buys cloud services, this is your supply chain too.

  4. 04

    OpenAI loosens the brakes on biology, for a guest list

    Of all the risks AI companies guard against, biology gets the tightest lock. OpenAI loosened it slightly on Friday with GPT-Rosalind-6, a version of its flagship model for drug discovery and medical research, which refuses fewer questions that could serve both medicine and weapons. OpenAI's safety report rates the model's biological capability as high, one step below OpenAI's top danger level. The safeguard is a guest list, with access only for vetted scientists, companies and governments. You saw the same shift in the mouse story, with AI moving from advising scientists to doing their work. For anyone in life sciences, a place on that list may soon matter more than the choice of model.

  5. 05

    Musk's xAI must answer for its gas turbines in court

    Electricity is the scarcest ingredient in AI right now, which tempts companies to cut corners getting it. A federal judge has let the NAACP, America's best-known civil rights organisation, go ahead with its lawsuit. It claims that Elon Musk's xAI ran at least 35 gas turbines without permits to power its Colossus data centre near Memphis. xAI argued that the turbines were mobile equipment needing no permit, and the judge disagreed. The timing matters, with data centres turning into a campaign issue ahead of Tuesday's midterm elections and New York already pausing approvals for new data centres. I expect the same fight in Europe, where data centres compete with homes and factories for power.

Want to stay updated on AI in your inbox?

Free, every morning. No spam, unsubscribe anytime.

Book Tim to speak

Book Tim →